Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib with CCRT for Locally Advanced Cervical Cancer
NCT04772001Phase 2Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Mar 2021
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in Cervical Cancer (CC), sponsored by Zhongnan Hospital of Wuhan University. Started Mar 2021; status: recruiting.
02
Drugs
anlotinib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04772001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772001.